Page last updated: 2024-08-21

alpha-aminopyridine and Dermatofibrosarcoma

alpha-aminopyridine has been researched along with Dermatofibrosarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bahri, N; Czaplinski, JT; Eilers, G; Fletcher, JA; Hornick, JL; Lindeman, NI; MariƱo-Enriquez, A; Mayeda, M; Sicinska, E; Tao, D; Wagner, AJ; Zhu, M1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Dermatofibrosarcoma

ArticleYear
CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:6

    Topics: Adult; Aged; Aminopyridines; Animals; Blotting, Western; Cell Line, Tumor; Collagen Type I; Collagen Type I, alpha 1 Chain; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p16; Dermatofibrosarcoma; Drug Resistance, Neoplasm; Gene Deletion; Gene Fusion; Humans; Imatinib Mesylate; Mice; Middle Aged; Phosphorylation; Piperazines; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-sis; Purines; Pyridines; Retinoblastoma Protein; RNA Interference; Xenograft Model Antitumor Assays; Young Adult

2015